Clinical Determinants for Successful Circulating Tumor DNA Analysis in Prostate Cancer

BACKGROUND: Plasma-based cell-free DNA is an attractive biospecimen for assessing somatic mutations due to minimally-invasive real-time sampling. However, next generation sequencing (NGS) of cell-free DNA (cfDNA) may not be appropriate for all patients with advanced prostate cancer (PC). METHODS: Bl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostate
Autori principali: Schweizer, Michael T., Gulati, Roman, Beightol, Mallory, Konnick, Eric Q., Cheng, Heather H., Klemfuss, Nola, Sarkar, Navonil De, Yu, Evan Y., Montgomery, R. Bruce, Nelson, Peter S., Pritchard, Colin C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589085/
https://ncbi.nlm.nih.gov/pubmed/30865311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23778
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi